Video index

1. Call to order

2. Consideration of July 22, 2022, draft meeting minutes

3. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment on single new drugs to be reviewed for the Medicaid PDL

5. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

8. Retrospective drug utilization review (DUR): Conduent, LLC

9. Prospective prior authorization proposals (clinical edits): Kepro, LLC

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: Jan 20, 2023, 9:00 a.m.

Oct 21, 2022 Drug Utilization Review Board (DURB) Agenda

Full agenda
Share this video

1. Call to order

2. Consideration of July 22, 2022, draft meeting minutes

3. Public comment on the drug classes to be reviewed for the Medicaid Preferred Drug List (PDL)

4. Public comment on single new drugs to be reviewed for the Medicaid PDL

5. Therapeutic and clinical drug reviews and updates: Magellan Medicaid Administration

6. Executive work session

7. Announcements of drugs recommended for the Medicaid PDL: Magellan Medicaid Administration

8. Retrospective drug utilization review (DUR): Conduent, LLC

9. Prospective prior authorization proposals (clinical edits): Kepro, LLC

10. Retrospective drug use criteria for outpatient use in Vendor Drug Program

11. Review of action items for next meeting: Jan 20, 2023, 9:00 a.m.

© 2003-2024 Swagit Productions, LLC